Terms ending in 2031
Every in-force patent on Pharmacyclics, Inc.'s record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,987,233 | Bruton's Tyrosine Kinase Activity Probe and Method of Using In force · High confidence | Pharmacyclics LLC | In force | High confidence | |
| US 8,754,090 | Use of Inhibitors of Bruton's Tyrosine Kinase (BTK) In force · Medium confidence | Pharmacyclics LLC | In force | Medium confidence | |
| US 8,999,999 | Use of Inhibitors of Bruton's Tyrosine Kinase (BTK) In force · Medium confidence | Pharmacyclics LLC | In force | Medium confidence | |
| US 9,125,889 | Use of Inhibitors of Bruton's Tyrosine Kinase (BTK) In force · Medium confidence | Pharmacyclics LLC | In force | Medium confidence | |
| US 9,801,881 | Use of Inhibitors of Bruton's Tyrosine Kinase (BTK) In force · Medium confidence | Pharmacyclics LLC | In force | Medium confidence | |
| US 9,801,883 | Use of Inhibitors of Bruton's Tyrosine Kinase (BTK) In force · Medium confidence | Pharmacyclics LLC | In force | Medium confidence | |
| US 9,814,721 | Use of Inhibitors of Bruton's Tyrosine Kinase (BTK) In force · High confidence | Pharmacyclics LLC | In force | High confidence | |
| US 10,004,745 | Use of Inhibitors of Bruton's Tyrosine Kinase (BTK) In force · Medium confidence | Pharmacyclics LLC | In force | Medium confidence | |
| US 10,004,746 | Use of Inhibitors of Bruton's Tyrosine Kinase (BTK) In force · Medium confidence | Pharmacyclics LLC | In force | Medium confidence | |
| US 10,016,435 | Use of Inhibitors of Bruton's Tyrosine Kinase (BTK) In force · High confidence | Pharmacyclics LLC | In force | High confidence | |
| 5 more term ends in 2031 · Pro | |||||
10 of 15 patents shown. Soonest term end first, then patent number.
Pro members see all 15.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.